gip and glp 1 mechanism of action Drug of GLP-1 analogues, DPP-IV inhibitors, Intracellular actions of GIP and

Debatri Datta, MBBS, MD Dermatology , Venereology & Leprosy Skin Whitening Injections: Skin whitening injections contain glutathione, a skin lightening agent that minimises the production of an enzyme called tyrosinase, which increases the melanin levels

ED can come from blood vessel issues, nerve signal issues, hormones, medicines, or mental strain

As consumer needs evolve, brands must zero in on the healthy innovations that matter most

Alasadi EA, Choi W, Chen X, Cotruvo JA Jr., Baiz CR (2024) Lanmodulins EF 2-3 domain: insights from infrared spectroscopy and simulations

Examples Canagliflozin (Invokana) Dosage Initial: 100 mg once daily before the first meal of the day Maximum: 300 mg once daily Dapagliflozin (Farxiga) Dosage Initial: 510 mg once daily Maximum: 10 mg once daily Empagliflozin (Jardiance) Dosage Initial: 10 mg once daily Maximum: 25 mg once daily Possible side effects include: Urinary tract infections Genital fungal (mycotic) infections (ie, Candida infection) Hypovolemia (low extracellular fluid) and hypotension (low blood pressure) Acute kidney injury, possibly as a result of volume depletion (limited and contradictory evidence) Diabetic ketoacidosis (rare) Osteoporosis and bone fractures Dipeptidyl peptidase-IV (DPP-4) inhibitors Primary mechanism(s) of action Enhance incretin signaling via inhibition of the enzyme dipeptidyl peptidase-IV (DPP-4), which breaks down GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)